The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > PLAGL1 protein, human

PLAGL1 protein, human

PLAGL1 (pleiomorphic adenoma gene-like 1) is a gene that encodes a zinc finger protein involved in the regulation of cell growth and apoptosis.
The PLAGL1 protein plays a role in the development and function of various tissues, including the pancreas, placenta, and nervous system.
Alterations in PLAGL1 expression have been implicated in several diseases, such as cancer, diabetes, and imprinting disorders.
Researchers studying PLAGL1 can utilize PubCompare.ai's AI-driven platform to identify the most reliable experimental protocols and products, enabling improved reproducibility and accuracy in their investigations.

Most cited protocols related to «PLAGL1 protein, human»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
A-301 Antibodies BRD4 protein, human CDK9 protein, human Chromatin Immunoprecipitation Sequencing DNA Chips histone H3 trimethyl Lys4 MED1 protein, human PLAGL1 protein, human RNA Polymerase II
The Big Five personality traits were measured using 25 self-descriptive adjective items (Lachman & Weaver, 1997 ; Prenda & Lachman, 2001 (link)). Each of the five personality traits was assessed with between 4 and 7 adjectives: Neuroticism (moody, worrying, nervous, calm [reverse scored]), Extraversion (outgoing, friendly, lively, active, talkative), Openness to Experience (creative, imaginative, intelligent, curious, broadminded, sophisticated, adventurous), Agreeableness (helpful, warm, caring, softhearted, sympathetic), and Conscientiousness (organized, responsible, hardworking, careless [reverse scored]). Participants indicated how well each adjective describes them on a 4-point scale, ranging from a lot (1) to not at all (4). For the purpose of calculating Cronbach’s alphas, ratings were reversely coded when necessary, so that higher scores reflect higher standing on each trait. Alpha internal consistency coefficients obtained in the exploratory and the analysis sample were .75 and .74 for Neuroticism, .75 and .78 for Extraversion, .78 and .77 for Openness to Experience, .83 and .80 for Agreeableness, and .53 and .58 for Conscientiousness.
Publication 2011
Extraversion, Psychological Imagination Nervousness Neuroticism PLAGL1 protein, human
A sodium bisulphite DNA modification protocol was used as described previously (7 (link)). The example data were derived from bisulphite sequencing of the differentially methylated region (DMR) in the imprinted ZAC (PLAGL1) tumour-suppressor gene (7 (link)). The reference sequence corresponds to nucleotides 48434376–48433838 of the Chromosome 6 assembly, accession NT_025741.14. PCR of bisulphite-modified DNA was carried out using the following primers, which amplify both methylated and unmethylated sequences: Zac9: dCCCAACCRTATCTAAATCAAAACT; and Zac1: dGTGTTTAGGATAGTGTTTGGTT. PCR conditions were as follows: denaturation at 94°C for 3 min followed by 35 cycles of 94°C, 30 s; 58°C, 30 s; 72°C, 30 s and a final extension step at 72°C for 3 min. PCR products were gel-extracted, purified using the Geneclean II kit (MP Biomedicals, Solon, OH, USA) and ligated into pGEM-T Easy vector (Promega, Madison, WI, USA) according to the manufacturer's protocol. Ligations were transformed into DH5α cells and DNA extracted from recombinant clones using the Qiaprep Spin miniprep kit (Qiagen, Valencia, CA, USA).
Publication 2007
Cells Chromosomes, Human, Pair 6 Clone Cells Cloning Vectors hydrogen sulfite Ligation Nucleotides Oligonucleotide Primers PLAGL1 protein, human Promega prostaglandin M sodium bisulfite Solon Tumor Suppressor Genes
We have previously described in detail the approach used at the Regeneron Genetics Center to perform exome sequencing in DNA samples from the UK Biobank study3 (link). In brief, genomic DNA samples were transferred to the Regeneron Genetics Center from the UK Biobank and stored in an automated sample biobank at −80 °C before sample preparation. DNA libraries were then created by enzymatically shearing DNA to a mean fragment size of 200 base pairs, and a common Y-shaped adapter was ligated to all DNA libraries. Unique, asymmetric 10-base-pair barcodes were added to the DNA fragment during library amplification to facilitate multiplexed exome capture and sequencing. Equal amounts of sample were pooled before overnight exome capture, with a slightly modified version of IDT’s xGen probe library. The initial 50,000 samples were processed with IDT ‘lot 1’ and all other samples with ‘lot 2’. The captured DNA was PCR-amplified and quantified by quantitative PCR. The multiplexed samples were pooled and then sequenced using 75-base-pair paired-end reads with two 10-base-pair index reads on the Illumina NovaSeq 6000 platform using S2 (first 50,000 samples) or S4 (all other samples) flow cells. We sequenced all samples delivered to us by the UK Biobank. A portion of samples (about 30,000) could not be delivered because of the COVID-19 pandemic.
Full text: Click here
Publication 2021
Base Pairing Cells COVID 19 DNA Library Exome Genome PLAGL1 protein, human
The subjective measure of the perceived neighborhood environment used an adapted version of the Neighborhood Environment Walkability Scale (NEWS) [9 (link)]. It comprises 67 items which are grouped into 8 factors:

Residential density—types of residences in the neighborhood

Land use mix—diversity (“Stores, facilities, and other things in your neighbourhood”)

was assessed by reports of facilities and amenities in the neighborhood, such as “About how long would it take to get from your home to the nearest businesses or facilities listed below if you walked to them?” and “How much it influences your participation in doing activities”

Street connectivity—includes streets in the neighborhood, places for walking and cycling and neighborhood surroundings

Land use mix—access (Access to services) such as “I can do most of my shopping at local stores”, “It is easy to walk to a transit stop (bus, train) from my home” (1 = strongly disagree, 2 = somewhat disagree, 3 = somewhat agree, 4 = strongly agree)

Infrastructure—places for walking and cycling

Aesthetics (Neighborhood surroundings)

Traffic safety

Safety from crime [10 (link), 11 (link)].

Objective measures of the neighborhood environment was based on Geographical Information System (GIS) variables measured in Euclidean or straight-line distances buffer within 500 m of the centroid of a neighborhood using the software ArcGIS® version 10 [12 ]:

Street connectivity—based on the number of true intersections within a given area, was defined by the number of street links divided by the number of street nodes within the buffer area.

Residential density—the number of dwelling units was divided by the land area in residential use within the area

Land use mix—the distribution of development across five uses (residential, commercial, industrial, recreation and other) is assessed to measure the land use mix.

Public park density—obtained by dividing the total area of public parks by the total area of the buffer and multiplying by 100

The Walkability Index was in turn derived as a composite value of combinations and weights of individual built environment characteristics, including residential density, street connectivity, land-use mix [13 (link)–16 (link)]. Since urban Singapore is characterized by a mixed land-used and compact urban environment, the net retail area was omitted in this study. Because of the unavailability of GIS layer of walkable paths within the study area, the impact of street networks is considered to be homogenous. “Residential lot coverage” and “street density” were used as proxy variables respectively for residential density and street connectivity. Therefore, the modified walkability index included residential lot coverage, street density and land-use mix. The built environment characteristics were measured in numerical values by ArcGIS® and Z-scores were calculated after arbitrarily dividing the whole study area into 18 zones (study area units). The constituent variables of walkability index, i.e. residential density, street density and land-use mix, were calculated based on the formulas provided in the Neighborhood Environment for Active Transport-Geographic Information Systems(NEAT-GIS) protocol [17 ]. Specifically,
Walkability index = Residential lot coverage + 1.5 × street density + land use mix
The Accessibility Index was assessed by measuring the walking access to 30 types of community service and amenity destinations to which proximity could plausibly encourage residents to walk more for leisure or transport [18 (link)]. Accessibility index is calculated for the 18 individual zones based on the multiplication of the sum of building weight within each zone and the residential density:
Accessibility index = building weights of the zone × residential density.
Both the Walkability and Accessibility Indexes were categorized into 3 levels, namely low, medium and high.
Physical activity (walking for transportation purpose); The study participants were also asked “How often do you walk from your house to (nearest) various types of businesses or facilities” with response ranging from never to daily. The scores of all items were summed and a higher scores denoting more frequently walking for transport. Transportation physical activity was the primary outcome of the analysis.
Covariates The study participant’s self-rated health was reported as ‘excellent’ , ‘very good’ , ‘good’ , ‘poor’ , or ‘very poor’. Physical Performance: gait and balance were measured with the performance oriented mobility assessment (POMA) tool [19 (link)]. Static sitting balance (rising from the sitting position without using hands) was assessed using graded scores by the need for assistance and the number of attempts; standing balance was assessed within the first 5 s after the subject’s sternum was gently pushed by the examiner, and when stance was stabilized. Staggering or excessive sway of the subject was examined with the subject standing and eyes closed. Steadiness and continuity of steps were observed with the subject turning in a complete 360° circle. The gait assessment was performed with the subject walking 6 m and returning quickly to the starting point, noting the ability to initiate walking and any hesitancy, step height and length, the lack of symmetry or inability to clear the floor, step continuity, deviation in the path and walking stance. The POMA scores for balance and gait were tallied separately using standard scoring criteria. Socio-demographic data included age, gender, ethnicity, educational attainment and housing type.
Full text: Click here
Publication 2015
Biological Transport, Active Buffers Crime Diet, Formula Ethnicity Eye Factor VIII Gender Homozygote Intersectional Framework Performance, Physical PLAGL1 protein, human Range of Motion, Articular Sternum

Most recents protocols related to «PLAGL1 protein, human»

Patients were assigned to 1 of 2 cohorts based on clinician assessment (Fig. 1). Training for TD screening (via videos) was provided to all clinical site personnel to promote inter-rater reliability. Cohort 1 was defined in the study protocol as patients who had no abnormal involuntary movements or whose movements were not consistent with possible TD based on clinician assessment. To avoid any potential overlap with patients with possible TD (as described below), this analysis focused on a modified Cohort 1 (no abnormal involuntary movements), which excluded patients with non-TD involuntary movements such as tremor.

Overview of possible TD symptom screen and cohort assignment. EQ-5D-5L, EuroQoL 5-dimension 5-level questionnaire; SDS, Sheehan Disability Scale; TD, tardive dyskinesia

Cohort 2 was defined in the study protocol as patients who had abnormal involuntary movements that were confirmed by their clinician as possible TD. All patients in Cohort 2 had a clinician-rated severity of possible TD as “some” or “a lot” in at least 1 of the following body regions: head/face, neck/trunk, upper extremities, and/or lower extremities. For this analysis, Cohort 2A (“aware”) was defined as patients with clinician-confirmed possible TD who also self-reported having abnormal involuntary movements within the past 4 weeks and had a self-rated severity of “some” or “a lot” in at least 1 of the 4 body regions. Data from Cohort 2NA (“not aware”), defined as patients with possible TD who self-reported having no abnormal involuntary movements in the past 4 weeks, were analyzed to provide supplementary information about the potential effects of patient awareness on HRQoL.
Full text: Click here
Publication 2023
Awareness Body Regions Disabled Persons Dyskinesias Face Head Involuntary Movements Lower Extremity Movement Neck Patients PLAGL1 protein, human Tremor Upper Extremity
Primary antibodies used were mouse-anti-Wingless (4D4-s; 1:120; DSHB, University of Iowa); mouse-anti-Patched (Apa1-s; 1:40; DSHB, University of Iowa); rat-anti-DE-cadherin (DCAD2 concentrate; 1:200; DSHB, University of Iowa); rabbit-anti-GFP (1:1000, Abcam ab6556, Lot:GR3404234-1); rabbit-anti-Phospho-Histone H3 (PHH3, 1:1000, Cell Signaling #9701); rabbit-anti-Mmp2 (1:500, from ref. 67 (link)); rabbit-anti-Vkg (1/500, from ref. 68 (link)).
Tissue outlines were marked by Alexa Fluor 660 Phalloidin (1:100, A 22285, Sigma-Aldrich) which was added together with the other secondary antibodies. Secondary antibodies used were Alexa 488 (donkey anti-mouse A21202, donkey anti-rabbit A21206), Alexa 568 (donkey anti-mouse A10037, donkey anti-rabbit A10042, goat anti-rat A11077) and Alexa 647 (donkey anti-rabbit A31573) from Invitrogen and Alexa 647 (donkey anti-mouse 715 605 151) from Jackson ImmunoResearch. Secondary antibodies were used at 1:500 dilution. Discs were blocked in 2% normal donkey serum (017-000-121, Jackson ImmunoResearch).
Full text: Click here
Publication 2023
alexa 568 Antibodies Cadherins Equus asinus Goat Histone H3 Mice, House MMP2 protein, human Phalloidine PLAGL1 protein, human Rabbits Serum Technique, Dilution Tissues
All patients’ DNA samples were initially tested for CNVs and aberrant methylation of the H19/IGF2:IG-DMR (imprinting centre 1, IC1), and KCNQ1OT1:TSS-DMR (IC2) in 11p15.5 by MS-MLPA (ME030, MRC-Holland, Amsterdam/NL) according to the manufacturer’s manual. In case of patients referred for SRS testing, the assay ME032 addressing the imprinted loci on chromosomes 6, 7, and 14 was used as well.
To identify MLID affecting the further ImpDis-associated iDMRs (PLAGL1:alt-TSS-DMR (PLAGL1), GRB10:alt-TSS-DMR (GRB10), MEST-alt-TSS-DMR (MEST), IC1, IC2, MEG3:TSS-DMR (MEG3), SNURF:TSS-DMR (SNURF), GNASA/B:TSS-DMR (GNASA/B), GNAS-NESP:TSS-DMR (GNAS-NESP), GNAS-AS1:TSS-DMR (GNAS-AS1), GNAS-XL:TSS-DMR (GNAS-XL)) as well as MEG8:Int2-DMR (MEG8) and PEG3:TSS-DMR (PEG3), the assay ME034 was applied. In case of evidence for aberrant methylation at the chromosomal regions 15q11.2, and 20q13.32, the assays ME028 and ME031 were used.
MLID was diagnosed if at least one of these 13 tested iDMRs was affected in addition to the disease-specific iDMR.
Full text: Click here
Publication 2023
Biological Assay Chromosomes, Human, Pair 2 Chromosomes, Human, Pair 6 Darbepoetin alfa GRB10 protein, human insulin-like growth factor 2, human KCNQ1OT1 protein, human Methylation Multiplex Ligation-Dependent Probe Amplification Patients PLAGL1 protein, human
The alfalfa seed (Alfalfa cultivar ‘Zhongmu No. 3’) was provided by a specialized seed producer (Xintai Zhouquan Agricultural Technology Co., LTD, China). The similar size of healthy and plump seeds was screened and then sorted into three groups (brown, yellow and green) according to the seed coat color by visual inspection. The seed proportion was calculated by counting the number of seeds with different colors. Yellow seeds comprised the major part (59%) of the seed lot used for this study, while the relative amount of brown seeds was 33%. Green seeds comprised only 8% of the seed lot (Table 1). GA3, D-IAA, D-ABA, D-GA4 were purchased from OlChemIm Ltd. (Olomouc, Czech Republic). IAA was purchased from LGC Standards Ltd. (Tetdington, UK). ABA was purchased from Sigma-Aldrich (Merck, Germany).
Full text: Click here
Publication 2023
Alfalfa PLAGL1 protein, human
LL-37 was purchased from Bio-Synthesis (lot #P6417-1), resuspended to 1 mg/mL in 0.01% acetic acid, and stored at −20 °C until needed. Starter cultures supplemented with chloramphenicol were diluted to an OD600 = 0.1 in specialized bicarbonate-containing media (24 (link), 45 (link)) supplemented with chloramphenicol. Cells were cultured shaking for 2.5 h at 37 °C after which cells were collected by centrifugation, resuspended with fresh bicarbonate-containing media without antibiotics to an OD600 = 0.1 (108 CFUs/mL), de-clumped by repeated (5×) passage through a 25 G blunt needle, and treated at 37 °C for 3 h with 150 µg/mL LL-37. Viable cells were enumerated by counting single colonies that formed overnight after plating serial dilutions of the treated cells.
Publication 2023
Acetic Acid Anabolism Antibiotics Cells Centrifugation Chloramphenicol Ion, Bicarbonate Needles PLAGL1 protein, human Technique, Dilution

Top products related to «PLAGL1 protein, human»

Sourced in United States, China, Germany, United Kingdom, Hong Kong, Canada, Switzerland, Australia, France, Japan, Italy, Sweden, Denmark, Cameroon, Spain, India, Netherlands, Belgium, Norway, Singapore, Brazil
The HiSeq 2000 is a high-throughput DNA sequencing system designed by Illumina. It utilizes sequencing-by-synthesis technology to generate large volumes of sequence data. The HiSeq 2000 is capable of producing up to 600 gigabases of sequence data per run.
Sourced in United States, United Kingdom
H3K27ac is a histone post-translational modification that is associated with the acetylation of lysine 27 on histone H3. This modification is generally found in the promoter regions of actively transcribed genes and is associated with active gene expression.
MKBP1333V is a lab equipment product manufactured by Merck Group. It serves as a core function for laboratory applications, providing essential functionality for research and analysis work. However, a detailed description while maintaining an unbiased and factual approach is not available.
Sourced in United Kingdom, United States, China, France, Japan, Italy
Ab1791 is a primary antibody targeting the protein Ki-67. It is suitable for use in immunohistochemistry and western blot applications. The product is provided as a liquid solution.
Sourced in United States, United Kingdom
H3K4me1 is a histone modification marker that is associated with active gene transcription. It serves as a recognition signal for proteins involved in chromatin remodeling and gene regulation. This product can be used for various applications in epigenetics research.
Sourced in United States, China, United Kingdom
H3K27me3 is a histone modification antibody that specifically recognizes the trimethylation of lysine 27 on histone H3 (H3K27me3). This epigenetic mark is associated with transcriptional repression and is involved in the regulation of gene expression and chromatin structure.
Sourced in United States, United Kingdom
H3K4me3 is a post-translational modification that involves the addition of three methyl groups to the fourth lysine residue of histone H3. This modification is associated with active gene transcription and is commonly used as a marker for actively transcribed genomic regions.
Sourced in United Kingdom, United States, Sweden
The NA934V is a laboratory centrifuge designed for general-purpose applications. It has a maximum speed of 6,000 rpm and a maximum RCF of 4,220 x g. The centrifuge can accommodate rotors for various tube sizes and types. Detailed specifications and intended use should be obtained from the manufacturer.
Sourced in United States
H3K27ac is a histone modification mark that is associated with active enhancers and promoters. It is a post-translational modification of the histone H3 protein, where the 27th lysine residue is acetylated.
Sourced in United States, United Kingdom, Germany, Canada, France, Australia, China, Japan, Italy, Switzerland, Netherlands
AMPure XP beads are a magnetic bead-based product used for the purification of nucleic acids, such as DNA and RNA, from various samples. The beads are designed to selectively bind to nucleic acids, allowing for the removal of contaminants and unwanted molecules during the purification process. The core function of AMPure XP beads is to provide an efficient and reliable method for the cleanup and concentration of nucleic acids in preparation for downstream applications.

More about "PLAGL1 protein, human"

The PLAGL1 (pleiomorphic adenoma gene-like 1) gene encodes a zinc finger protein that plays a crucial role in regulating cell growth and apoptosis.
This versatile protein is involved in the development and function of various tissues, including the pancreas, placenta, and nervous system.
Alterations in PLAGL1 expression have been linked to several diseases, such as cancer, diabetes, and imprinting disorders.
Researchers studying the PLAGL1 protein can leverage cutting-edge AI-driven platforms like PubCompare.ai to identify the most reliable experimental protocols and products.
This approach helps improve the reproducibility and accuracy of their investigations.
By accessing a wealth of data from literature, preprints, and patents, scientists can make informed decisions on the best methods and materials to use, such as HiSeq 2000 sequencing, H3K27ac and H3K4me1 histone modifications, MKBP1333V and NA934V gene variants, Ab1791 antibodies, and AMPure XP beads for DNA purification.
Integrating these insights can unlock new avenues of discovery in PLAGL1 research, leading to a deeper understanding of its role in health and disease.
Whether you're exploring the gene's involvement in cell signaling, its epigenetic regulation, or its diagnostic and therapeutic potential, PubCompare.ai's data-driven approach can be a valuable tool in your research arsenal.